{"id":5681,"date":"2005-07-06T10:06:00","date_gmt":"2005-07-06T10:06:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5681"},"modified":"2021-07-09T11:08:25","modified_gmt":"2021-07-09T11:08:25","slug":"leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/","title":{"rendered":"Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Diepolder+HM&amp;cauthor_id=16121358\">Helmut M Diepolder<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16121358\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kashiwagi+N&amp;cauthor_id=16121358\">Nobuhito Kashiwagi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Teuber+G&amp;cauthor_id=16121358\">Gerlinde Teuber<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ulsenheimer+A&amp;cauthor_id=16121358\">Axel Ulsenheimer<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Franz+M&amp;cauthor_id=16121358\">Marita Franz<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yokoyama+T&amp;cauthor_id=16121358\">Takashi Yokoyama<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Zachoval+R&amp;cauthor_id=16121358\">Reinhart Zachoval<\/a>, J Med Virol. 2005 Oct;77(2):209-15.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>&nbsp;The results indicate that activation of cellular immunity by leucocytapheresis facilitates an early virological response rate in HCV patients. This new therapy may, therefore, become an additional therapeutic measure for HCV.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16121358\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16121358\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Helmut M Diepolder&nbsp;1,&nbsp;Nobuhito Kashiwagi,&nbsp;Gerlinde Teuber,&nbsp;Axel Ulsenheimer,&nbsp;Marita Franz,&nbsp;Takashi Yokoyama,&nbsp;Reinhart Zachoval, J Med Virol. 2005 Oct;77(2):209-15. &nbsp;The results indicate that activation of cellular immunity by leucocytapheresis facilitates an early virological response rate in HCV patients. This new therapy may, therefore, become an additional therapeutic measure for HCV. https:\/\/pubmed.ncbi.nlm.nih.gov\/16121358\/<\/p>\n","protected":false},"template":"","scientific_tags":[314,404],"class_list":["post-5681","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-digestive","scientific_tags-hcv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1 - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1 - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Helmut M Diepolder&nbsp;1,&nbsp;Nobuhito Kashiwagi,&nbsp;Gerlinde Teuber,&nbsp;Axel Ulsenheimer,&nbsp;Marita Franz,&nbsp;Takashi Yokoyama,&nbsp;Reinhart Zachoval, J Med Virol. 2005 Oct;77(2):209-15. &nbsp;The results indicate that activation of cellular immunity by leucocytapheresis facilitates an early virological response rate in HCV patients. This new therapy may, therefore, become an additional therapeutic measure for HCV. https:\/\/pubmed.ncbi.nlm.nih.gov\/16121358\/\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:08:25+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/\",\"name\":\"Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1 - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2005-07-06T10:06:00+00:00\",\"dateModified\":\"2021-07-09T11:08:25+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1 - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/","og_locale":"de_DE","og_type":"article","og_title":"Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1 - Adacyte","og_description":"Helmut M Diepolder&nbsp;1,&nbsp;Nobuhito Kashiwagi,&nbsp;Gerlinde Teuber,&nbsp;Axel Ulsenheimer,&nbsp;Marita Franz,&nbsp;Takashi Yokoyama,&nbsp;Reinhart Zachoval, J Med Virol. 2005 Oct;77(2):209-15. &nbsp;The results indicate that activation of cellular immunity by leucocytapheresis facilitates an early virological response rate in HCV patients. This new therapy may, therefore, become an additional therapeutic measure for HCV. https:\/\/pubmed.ncbi.nlm.nih.gov\/16121358\/","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:08:25+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/","name":"Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1 - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2005-07-06T10:06:00+00:00","dateModified":"2021-07-09T11:08:25+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-with-adacolumn-enhances-hcv-specific-proliferative-responses-in-patients-infected-with-hepatitis-c-virus-genotype-1\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/5681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=5681"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=5681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}